Constitutive activation of JAK1 in Src-transformed cells
- PMID: 9006890
- DOI: 10.1074/jbc.272.5.2591
Constitutive activation of JAK1 in Src-transformed cells
Abstract
We have previously found that the signal transducer and activator of transcription (Stat) 3 is constitutively activated in cells stably transformed by the v-Src oncoprotein. While activation of Stat proteins has also been observed following epidermal growth factor or platelet-derived growth factor stimulation, Stat3 activation is more commonly associated with signaling through cytokine receptors and activation of the Janus family tyrosine kinases JAK1 or JAK2. We therefore investigated whether JAK1 or JAK2 were activated in Src-transformed cells. In three v-Src-transformed fibroblast cell lines (NIH3T3, Balb/c, and 3Y1), JAK1 displayed increased tyrosyl phosphorylation compared to non-transformed cells. The level of tyrosyl phosphorylation of JAK1 was significantly greater in NIH3T3 cells transformed by expression of v-Src or high levels of a constitutively active mutant of c-Src (Y527F) than in cells overexpressing the less transforming normal c-Src. Enzymatic activity of JAK1 was assessed using autophosphorylation assays. In anti-JAK1 immunoprecipitates from v-Src-transformed NIH3T3 cells, a protein with the same migration as JAK1 showed substantially increased levels of 32P incorporation compared to immunoprecipitates from non-transformed cells. Similar results were obtained using anti-JAK2 immunoprecipitates; however, the level of JAK2 tyrosyl phosphorylation and 32P incorporation in anti-JAK2 immunoprecipitates were markedly lower than in anti-JAK1 immunoprecipitates. We conclude that JAK1, and possibly JAK2, are constitutively activated in Src-transformed cells, raising the possibility that Janus family kinases contribute to the constitutive activation of Stat3 previously observed in these cells and/or other properties of Src-transformed cells.
Similar articles
-
Activation of Stat3 in v-Src-transformed fibroblasts requires cooperation of Jak1 kinase activity.J Biol Chem. 2000 Aug 11;275(32):24935-44. doi: 10.1074/jbc.M002383200. J Biol Chem. 2000. PMID: 10823829
-
The JAK-inhibitor, JAB/SOCS-1 selectively inhibits cytokine-induced, but not v-Src induced JAK-STAT activation.Oncogene. 2000 Sep 28;19(41):4795-801. doi: 10.1038/sj.onc.1203829. Oncogene. 2000. PMID: 11032030
-
The role of the growth hormone (GH) receptor and JAK1 and JAK2 kinases in the activation of Stats 1, 3, and 5 by GH.Mol Endocrinol. 1996 May;10(5):519-33. doi: 10.1210/mend.10.5.8732683. Mol Endocrinol. 1996. PMID: 8732683
-
Progestins induce transcriptional activation of signal transducer and activator of transcription 3 (Stat3) via a Jak- and Src-dependent mechanism in breast cancer cells.Mol Cell Biol. 2005 Jun;25(12):4826-40. doi: 10.1128/MCB.25.12.4826-4840.2005. Mol Cell Biol. 2005. PMID: 15923602 Free PMC article.
-
Platelet-derived growth factor (PDGF)-induced activation of signal transducer and activator of transcription (Stat) 5 is mediated by PDGF beta-receptor and is not dependent on c-src, fyn, jak1 or jak2 kinases.Biochem J. 2000 Feb 1;345 Pt 3(Pt 3):759-66. Biochem J. 2000. PMID: 10642538 Free PMC article.
Cited by
-
STAT signaling in the pathogenesis and treatment of cancer.Mol Med. 1999 Jul;5(7):432-56. Mol Med. 1999. PMID: 10449805 Free PMC article. Review.
-
Thymoquinone inhibits proliferation, induces apoptosis and chemosensitizes human multiple myeloma cells through suppression of signal transducer and activator of transcription 3 activation pathway.Br J Pharmacol. 2010 Oct;161(3):541-54. doi: 10.1111/j.1476-5381.2010.00874.x. Br J Pharmacol. 2010. PMID: 20880395 Free PMC article.
-
An EGF receptor/Ral-GTPase signaling cascade regulates c-Src activity and substrate specificity.EMBO J. 2000 Feb 15;19(4):623-30. doi: 10.1093/emboj/19.4.623. EMBO J. 2000. PMID: 10675331 Free PMC article.
-
Hepatitis C virus (HCV) constitutively activates STAT-3 via oxidative stress: role of STAT-3 in HCV replication.J Virol. 2005 Feb;79(3):1569-80. doi: 10.1128/JVI.79.3.1569-1580.2005. J Virol. 2005. Retraction in: J Virol. 2020 Sep 15;94(19):e01358-20. doi: 10.1128/JVI.01358-20. PMID: 15650183 Free PMC article. Retracted.
-
Binding of galectin-1 to integrin β1 potentiates drug resistance by promoting survivin expression in breast cancer cells.Oncotarget. 2017 May 30;8(22):35804-35823. doi: 10.18632/oncotarget.16208. Oncotarget. 2017. PMID: 28415760 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous